Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for CPAP Non-Adherent Veterans With PTSD and Complex Insomnia
NCT03265951Phase 4Withdrawn
- Sponsor
- University at Buffalo
- Start
- Jan 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ramelteon in Insomnia (2 arms), sponsored by University at Buffalo. Primary endpoint: Pittsburgh Sleep Quality Index at 12 weeks. Planned start Jan 2018; status: withdrawn.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03265951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265951.